See what questions
a doctor would ask.
Two new drugs have recently been approved by the FDA. Tysabri is a monoclonal antibody treatment for multiple sclerosis and is the first of its kind. 10,000 new cases of MS are diagnosed annually in the US claims the MS Association of America. The other approved drug is Tarceva which is a lung cancer treatment. It does have some side effects but the benefits out weigh this. In trials, the drug improved one-year survival rate from 4.7 months to 6.7 months and the median survival rate was improved from 21.5% to 31.2%. However, the drug costs over $2,000 for a month's supply.
Source: summary of medical news story as reported by Axcess News
About: Two new drugs approved by FDA
Date: 27 November 2004
Source: Axcess News
Author: Freddie Mooche
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City